Silence Therapeutics SLN
NASDAQ SLN
$19.67 +0.06 (+0.28%)
As of: Oct 21, 2026 · 2:50 PM EDT

Silence Therapeutics (SLN) Common Stock Issued (2024 - 2026)

Updated

Analysis

Silence Therapeutics (SLN) Common Stock Issued (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,136.71 Bn 1,105.29 Bn 19.71 Bn -
2 Johnson & Johnson 617.55 Bn 536.07 Bn 17.26 Bn 359.00 Mn
3 AbbVie 501.02 Bn 474.13 Bn 12.70 Bn -
4 Merck 368.18 Bn 322.56 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 297.89 Bn 261.88 Bn 11.24 Bn -
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 6.00 Mn
7 Amgen 236.60 Bn 191.99 Bn 7.24 Bn -
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn 9.00 Mn
9 Pfizer 169.77 Bn 116.42 Bn 10.94 Bn -
10 Silence Therapeutics 928.91 Mn 856.81 Mn - 2,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 14,000.00
Dec 31, 2024 -98,000.00
Sep 30, 2024 7.97 Mn
Jun 30, 2024 1.19 Mn
Mar 31, 2024 133.02 Mn
API Access

Silence Therapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=SLN&period=max&api_key=YOUR_API_KEY